Researchers from the Inter-University Faculty of Biotechnology at the University of Gdansk and the Medical University of Gdansk have developed an amino acid sequence of recombinant virus-like particles (VLPs), which could form the basis of a vaccine against tick-borne encephalitis virus. The invention has been patented.

Invertebrate-borne viral infectious diseases are a major public health problem in all parts of the world. One disease of increasing importance to the EU is tick-borne encephalitis (TBE). It is a central nervous system disorder that can lead to serious medical complications, including meningitis, encephalitis or myelitis. 

VLPs particles are structures that mimic the virus and are capable of inducing an immune response against it but are unable to multiply in the human or animal body and incapable of causing infection.

Read more: https://ug.edu.pl/news/pl/6635/patent-dla-naukowcow-z-zakladu-szczepionek-rekombinowanych